IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
In 2021, the World Health Organization classified isocitrate dehydrogenase (<i>IDH</i>) mutant gliomas as a distinct subgroup of tumors with genetic changes sufficient to enable a complete diagnosis. Patients with an <i>IDH</i> mutant glioma have improved survival which has b...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/13/11/885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|